Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : The New QLogic (ANCR) -- Ignore unavailable to you. Want to Upgrade?

To: Bill who wrote (17443)	7/27/1998 11:48:00 AM
From: Joe13579	Read Replies (1) \| Respond to of 29386

<<management would be forced to accept a 200% premium if it came along>> Sorry Bill, you are wrong. There is a lot more than just the stock price at issue when a buyout offer is presented. Management cannot be forced to change their officers/employees/location. Management cannot be forced to erase poison pill provisions already in place. I won't get into technicals with you, it's true that anybody can make a hostile offer for $6/share, but there is no fiduciary duty on behalf of the officers to sell Ancor at a 200% premium just to satisfy their stockholders; the fiduciary duty that the officers do have is to make decisions based on the best interests of the company. Rob

To: Bill who wrote (17443)	7/27/1998 12:14:00 PM
From: Patrick Sharkey	Read Replies (1) \| Respond to of 29386

Bill, you have stated several times that management would have to accept a deal at a certain number, but I disagree with such a broad statement. The law reporters are filled with cases in which shareholders sued because management refused to accept a buyout, and because management sold too cheaply. Management is given great latitude in managing the business, and in deciding, as an initial matter, whether to sell the company. There is far more that is unknown about Ancor, than what we do know about its position at this point. l